University of Iowa Sues Abbott Claiming Humira Manufacture Infringes CMV Promoter IP

The suit, filed by the UI Research Foundation, claims that Abbott has infringed one or more claims of the patents by manufacturing its billion-dollar blockbuster monoclonal antibody Humira, which is used to treat a variety of autoimmune diseases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.